Variations in folate pathway genes are associated with unexplained female infertility

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 130-137

  Altmäe, Signe ^a,b   Stavreus Evers, Anneli ^c   Ruiz, Jonatan R ^a   Laanpere, Margit ^b   Syvänen, Tiina ^c   Yngve, Agneta ^a   Salumets, Andres ^b   Nilsson, Torbjörn K ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CTH; Female infertility; FOLR1; homocysteine; MTHFR; SLC19A1; TCN2

Indexed keywords

CYANOCOBALAMIN; CYSTATHIONINE GAMMA LYASE; FOLATE RECEPTOR; FOLATE RECEPTOR 1; FOLIC ACID; HOMOCYSTEINE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; REDUCED FOLATE CARRIER; TRANSCOBALAMIN II; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; FOLIC ACID BLOOD LEVEL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; CYSTATHIONINE GAMMA-LYASE; FEMALE; FOLIC ACID; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; HOMOCYSTEINE; HUMANS; INFERTILITY, FEMALE; MEMBRANE TRANSPORT PROTEINS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSCOBALAMINS; VITAMIN B 12;

EID: 77952668920     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.025     Document Type: Article

References (49)

1. Tamura T., and Picciano M.F. Folate and human reproduction. Am J Clin Nutr 83 (2006) 993-1016
2. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
3. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71 (2000) 121-138
4. Gmyrek G.B., Sozanski R., Jerzak M., Chrobak A., Wickiewicz D., Skupnik A., et al. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol 122 (2005) 199-205
5. Thaler C.D., and Epel D. Nitric oxide in oocyte maturation, ovulation, fertilization, cleavage and implantation: a little dab'll do ya. Curr Pharm Des 9 (2003) 399-409
6. Agarwal A., Gupta S., and Sharma R.K. Role of oxidative stress in female reproduction. Reprod Biol Endocrinol 3 (2005) 28
7. Hussein M.R. Apoptosis in the ovary: molecular mechanisms. Hum Reprod Update 11 (2005) 162-177
8. Forges T., Monnier-Barbarino P., Alberto J.M., Gueant-Rodriguez R.M., Daval J.L., and Gueant J.L. Impact of folate and homocysteine metabolism on human reproductive health. Hum Reprod Update 13 (2007) 225-238
9. Mooij P.N., Wouters M.G., Thomas C.M., Doesburg W.H., and Eskes T.K. Disturbed reproductive performance in extreme folic acid deficient golden hamsters. Eur J Obstet Gynecol Reprod Biol 43 (1992) 71-75
10. Boxmeer J.C., Brouns R.M., Lindemans J., Steegers E.A., Martini E., Macklon N.S., et al. Preconception folic acid treatment affects the microenvironment of the maturing oocyte in humans. Fertil Steril 89 (2008) 1766-1770
11. Chavarro J.E., Rich-Edwards J.W., Rosner B.A., and Willett W.C. Use of multivitamins, intake of B vitamins, and risk of ovulatory infertility. Fertil Steril 89 (2008) 668-676
12. Zetterberg H. Methylenetetrahydrofolate reductase and transcobalamin genetic polymorphisms in human spontaneous abortion: biological and clinical implications. Reprod Biol Endocrinol 2 (2004) 7
13. Narayanan S., McConnell J., Little J., Sharp L., Piyathilake C.J., Powers H., et al. Associations between two common variants C677T and A1298C in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 13 (2004) 1436-1443
14. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
15. Yamada K., Strahler J.R., Andrews P.C., and Matthews R.G. Regulation of human methylenetetrahydrofolate reductase by phosphorylation. Proc Natl Acad Sci U S A 102 (2005) 10454-10459
16. Harmon D.L., Woodside J.V., Yarnell J.W., McMaster D., Young I.S., McCrum E.E., et al. The common "thermolabile" variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia. QJM 89 (1996) 571-577
17. Altmae S., Haller K., Peters M., Hovatta O., Stavreus-Evers A., Karro H., et al. Allelic estrogen receptor 1 (ESR1) gene variants predict the outcome of ovarian stimulation in in vitro fertilization. Mol Hum Reprod 13 (2007) 521-526
18. WHO. Laboratory manual for the examination of human semen and sperm-cervical mucus interaction. 4th ed. (1999), Cambridge University Press, Cambridge
19. Böttiger A.K., Hagnelius N.O., and Nilsson T.K. Mutations in exons 2 and 3 of the FOLR1 gene in demented and non-demented elderly subjects. Int J Mol Med 20 (2007) 653-662
20. Böttiger A.K., Hurtig-Wennlof A., Sjostrom M., Yngve A., and Nilsson T.K. Association of total plasma homocysteine with methylenetetrahydrofolate reductase genotypes 677C>T, 1298A>C, and 1793G>A and the corresponding haplotypes in Swedish children and adolescents. Int J Mol Med 19 (2007) 659-665
21. Böttiger A.K., and Nilsson T.K. Pyrosequencing assay for genotyping of the Transcobalamin II 776C>G polymorphism. Scand J Clin Lab Invest 67 (2007) 247-251
22. Nilsson T.K., Lof-Ohlin Z.M., and Bottiger A.K. Genotyping of the reduced folate carrier-1 c.80G>A polymorphism by pyrosequencing technology: importance of PCR and pre-PCR optimization. Scand J Clin Lab Invest 68 (2008) 166-170
23. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
24. Szymanski W., and Kazdepka-Zieminska A. Effect of homocysteine concentration in follicular fluid on a degree of oocyte maturity. Ginekol Pol 74 (2003) 1392-1396
25. Ebisch I.M., Peters W.H., Thomas C.M., Wetzels A.M., Peer P.G., and Steegers-Theunissen R.P. Homocysteine, glutathione and related thiols affect fertility parameters in the (sub)fertile couple. Hum Reprod 21 (2006) 1725-1733
26. Pacchiarotti A., Mohamed M.A., Micara G., Linari A., Tranquilli D., Espinola S.B., et al. The possible role of hyperhomocysteinemia on IVF outcome. J Assist Reprod Genet 24 (2007) 459-462
27. Fohr I.P., Prinz-Langenohl R., Bronstrup A., Bohlmann A.M., Nau H., Berthold H.K., et al. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 75 (2002) 275-282
28. Wang J., Huff A.M., Spence J.D., and Hegele R.A. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration. Clin Genet 65 (2004) 483-486
29. Jongbloet P.H., Verbeek A.L., den Heijer M., and Roeleveld N. Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms resulting in suboptimal oocyte maturation: a discussion of folate status, neural tube defects, schizophrenia, and vasculopathy. J Exp Clin Assist Reprod 5 (2008) 5
30. Thaler C.J., Budiman H., Ruebsamen H., Nagel D., and Lohse P. Effects of the common 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene on ovarian responsiveness to recombinant follicle-stimulating hormone. Am J Reprod Immunol 55 (2006) 251-258
31. Haggarty P., McCallum H., McBain H., Andrews K., Duthie S., McNeill G., et al. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet 367 (2006) 1513-1519
32. Bae J., Shin S.J., Cha S.H., Choi D.H., Lee S., and Kim N.K. Prevalent genotypes of methylenetetrahydrofolate reductase (MTHFR C677T and A1298C) in spontaneously aborted embryos. Fertil Steril 87 (2007) 351-355
33. Reyes-Engel A., Munoz E., Gaitan M.J., Fabre E., Gallo M., Dieguez J.L., et al. Implications on human fertility of the 677C→T and 1298A→C polymorphisms of the MTHFR gene: consequences of a possible genetic selection. Mol Hum Reprod 8 (2002) 952-957
34. Rady P.L., Szucs S., Grady J., Hudnall S.D., Kellner L.H., Nitowsky H., et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas; a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 107 (2002) 162-168
35. Chen J., Ma J., Stampfer M.J., Palomeque C., Selhub J., and Hunter D.J. Linkage disequilibrium between the 677C>T and 1298A>C polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics 12 (2002) 339-342
36. Shi M., Caprau D., Romitti P., Christensen K., and Murray J.C. Genotype frequencies and linkage disequilibrium in the CEPH human diversity panel for variants in folate pathway genes MTHFR, MTHFD, MTRR, RFC1, and GCP2. Birth Defects Res A Clin Mol Teratol 67 (2003) 545-549
37. Ueland P.M., Hustad S., Schneede J., Refsum H., and Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 22 (2001) 195-201
38. Coulam C.B., Jeyendran R.S., Fishel L.A., and Roussev R. Multiple thrombophilic gene mutations are risk factors for implantation failure. Reprod Biomed Online 12 (2006) 322-327
39. Keijzer M.B., den Heijer M., Blom H.J., Bos G.M., Willems H.P., Gerrits W.B., et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolatereductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88 (2002) 723-728
40. Azem F., Many A., Ben Ami I., Yovel I., Amit A., Lessing J.B., et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod 19 (2004) 368-370
41. Rawlings N.D., and Barrett A.J. Evolutionary families of peptidases. Biochem J 290 (1993) 205-218
42. Matherly L.H., Hou Z., and Deng Y. Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastasis Rev 26 (2007) 111-128
43. Chango A., Emery-Fillon N., de Courcy G.P., Lambert D., Pfister M., Rosenblatt D.S., et al. A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70 (2000) 310-315
44. Whetstine J.R., Gifford A.J., Witt T., Liu X.Y., Flatley R.M., Norris M., et al. Single nucleotide polymorphisms in the human reduced folate carrier: characterization of a high-frequency G/A variant at position 80 and transport properties of the His(27) and Arg(27) carriers. Clin Cancer Res 7 (2001) 3416-3422
45. Nelen W.L., Bulten J., Steegers E.A., Blom H.J., Hanselaar A.G., and Eskes T.K. Maternal homocysteine and chorionic vascularization in recurrent early pregnancy loss. Hum Reprod 15 (2000) 954-960
46. Yates Z., and Lucock M. G80A reduced folate carrier SNP modulates cellular uptake of folate and affords protection against thrombosis via a non homocysteine related mechanism. Life Sci 77 (2005) 2735-2742
47. Rey E., Kahn S.R., David M., and Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361 (2003) 901-908
48. Gleicher N., and Barad D. Unexplained infertility: does it really exist?. Hum Reprod 21 (2006) 1951-1955
49. Olive D.L., and Schwartz L.B. Endometriosis. N Engl J Med 328 (1993) 1759-1769